---
figid: PMC6953314__12974_2020_1701_Fig3_HTML
figlink: pmc/articles/PMC6953314/figure/Fig3/
number: Fig. 3
caption: Intracellular signaling pathways of CAP, SNS, and HPA axis for anti-inflammatory
  responses. Acetylcholine (Ach) can be released from the terminal efferent vagus
  nerve and further interacts with α7 nicotinic acetylcholine receptor (α7nAChR) on
  immune cells. Activation of α7nAChR triggers multiple intracellular signaling pathways,
  including promoting phosphorylation of Janus kinase 2 (JAK2)-signal transducer and
  activator of transcription 3 (STAT3) pathway, inhibiting Toll-like receptor (TLR)4-myeloid
  differentiation factor 88 (MyD88)-interleukin-1 receptor-associated kinase (IRAK)
  cascade as well as declining release of mitochondrial DNA, which contribute to suppression
  of proinflammatory phenotypes by disturbing activation of nuclear factor-κB (NF-κB)
  and inflammasomes. The interaction between glucocorticoids and glucocorticoid receptors
  (GRs) is capable of inhibiting production of proinflammatory cytokines by downregulating
  NF-κB activity and disturbing c-jun amino-terminal kinase (JNK) cascade after Toll-like
  receptor (TLR)7 and TLR8 stimulation. Activation of β2-adrenergic receptor with
  norepinephrine promotes the expression of cyclic AMP (cAMP) and activation of protein
  kinase A (PKA), which results in decreased production of proinflammatory cytokines
  by suppressing translocation of NF-κB. It also increases expression of fibroblast
  growth factor 21 (FGF21) which further suppresses NF-κB activation by promoting
  activation of extracellular signal regulated kinase (ERK) 1/2-STAT3 cascades in
  an autocrine manner
pmcid: PMC6953314
papertitle: 'Sepsis-associated encephalopathy: a vicious cycle of immunosuppression.'
reftext: Chao Ren, et al. J Neuroinflammation. 2020;17:14.
pmc_ranked_result_index: '62312'
pathway_score: 0.9287403
filename: 12974_2020_1701_Fig3_HTML.jpg
figtitle: Intracellular signaling pathways of CAP, SNS, and HPA axis for anti-inflammatory
  responses
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6953314__12974_2020_1701_Fig3_HTML.html
  '@type': Dataset
  description: Intracellular signaling pathways of CAP, SNS, and HPA axis for anti-inflammatory
    responses. Acetylcholine (Ach) can be released from the terminal efferent vagus
    nerve and further interacts with α7 nicotinic acetylcholine receptor (α7nAChR)
    on immune cells. Activation of α7nAChR triggers multiple intracellular signaling
    pathways, including promoting phosphorylation of Janus kinase 2 (JAK2)-signal
    transducer and activator of transcription 3 (STAT3) pathway, inhibiting Toll-like
    receptor (TLR)4-myeloid differentiation factor 88 (MyD88)-interleukin-1 receptor-associated
    kinase (IRAK) cascade as well as declining release of mitochondrial DNA, which
    contribute to suppression of proinflammatory phenotypes by disturbing activation
    of nuclear factor-κB (NF-κB) and inflammasomes. The interaction between glucocorticoids
    and glucocorticoid receptors (GRs) is capable of inhibiting production of proinflammatory
    cytokines by downregulating NF-κB activity and disturbing c-jun amino-terminal
    kinase (JNK) cascade after Toll-like receptor (TLR)7 and TLR8 stimulation. Activation
    of β2-adrenergic receptor with norepinephrine promotes the expression of cyclic
    AMP (cAMP) and activation of protein kinase A (PKA), which results in decreased
    production of proinflammatory cytokines by suppressing translocation of NF-κB.
    It also increases expression of fibroblast growth factor 21 (FGF21) which further
    suppresses NF-κB activation by promoting activation of extracellular signal regulated
    kinase (ERK) 1/2-STAT3 cascades in an autocrine manner
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR7
  - TLR4
  - MYD88
  - IRAK4
  - JAK2
  - MAPK8
  - MAPK9
  - MAPK10
  - IRAK2
  - TRAF6
  - STAT3
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - FGFR4
  - FGFRL1
  - FGFR1
  - FGFR3
  - FGFR2
  - FGF21
  - BTG3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
genes:
- word: TLR7
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: Myd88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IRAK2
  symbol: IRAK2
  source: hgnc_symbol
  hgnc_symbol: IRAK2
  entrez: '3656'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGF21
  symbol: FGF21
  source: hgnc_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: aNA
  symbol: ANA
  source: hgnc_alias_symbol
  hgnc_symbol: BTG3
  entrez: '10950'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: FGF21
  symbol: FGF21
  source: hgnc_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: FGF21
  symbol: FGF21
  source: hgnc_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Ach
  symbol: ACH
  source: hgnc_prev_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
chemicals: []
diseases: []
---
